Read the latest positive news, breakthroughs, and inspiring stories about obesity treatment, curated daily by BrightWire.
Novo Nordisk's experimental obesity medication helped women lose 25% of their body weight on average in a major clinical trial. The drug appears especially promising for women going through menopause, a time when weight gain becomes particularly challenging.
An experimental weekly injection helped people lose an average of 25% of their body weight in 80 weeks, while also reducing knee pain and sleep breathing problems. The phase 3 trial tracked over 2,300 adults, offering new hope for treating obesity and related health conditions.
Since Medicare began covering obesity medications in July, 700,000 seniors have started life-changing weight loss treatments. The new coverage program is making these breakthrough drugs accessible to millions who couldn't afford them before.
After bariatric surgery and years of frustration, a 71-year-old woman lost 105 pounds when genetic testing revealed the real cause of her lifelong obesity. New FDA-approved medications are transforming treatment for people whose weight challenges stem from rare genetic conditions.
China just approved Wegovy to treat severe fatty liver disease, giving hope to millions who previously had no effective medication. The breakthrough comes as one in three Chinese adults battles this often-silent condition.
A clinical trial shows the keto diet dramatically reduced liver fat and reversed prediabetes in half of participants with obesity in just five months. The results suggest food choices matter as much as weight loss itself.
A South Korean pharmaceutical company just secured the biggest tech deal in the nation's history for an obesity drug that keeps muscle while burning fat. This breakthrough could transform how millions lose weight safely.
Researchers at UC Berkeley have discovered a compound that helps mice lose fat while preserving muscle, offering a potential alternative to appetite-suppressing drugs like Ozempic. The treatment works by boosting metabolism instead of reducing hunger.
Scientists are developing obesity medications that prioritize fewer side effects and better long-term health outcomes over extreme weight loss. Yale researchers say the next generation of treatments could preserve muscle and bone while helping millions stick with their medications.
Scientists have successfully tested a pill that mimics the chemistry of exercise in humans for the first time. The drug ENV-308 showed no serious side effects and could help people maintain weight loss without the stomach problems common to current obesity medications.
A once-daily pill called aleniglipron helped people lose up to 12% of their body weight in just nine months, offering a simpler alternative to injectable obesity medications. Unlike current treatments that require needles and refrigeration, this small-molecule drug could be easier to produce and more accessible to millions.
Scientists discovered Ozempic works differently than everyone thought, recruiting hunger neurons to burn fat instead of just suppressing appetite. This breakthrough could lead to even better weight loss medications.